Orphan Medicinal Products Regulation
Proposal for a EUROPEAN PARLIAMENT AND COUNCIL REGULATION (EC) on orphan medicinal products
- Stage
- In force, reached 22 Jan 2000
- In force
- In force since 22 Jan 2000 · CELEX 32000R0141
- Procedure
- Regulation · Ordinary legislative procedure
- Last activity
- 22 Jan 2000
Delegated and implementing acts beneath it
By status: 1 published.
| Act | Kind | Status | Adoption |
|---|---|---|---|
| Commission Implementing Regulation (EU) 2018/781 | Implementing · Regulation | Published |
Titles link to EUR-Lex where the act has been published.
Documents
Newest first. Each opens at its source.
- Report · A4-0078/1999Parliament
- Report · A5-0080/1999Parliament
- OJ C 101 12.04.1999, p. 0037Commission
- OJ C 175 21.06.1999, p. 0004Commission
- OJ C 194 11.07.2000, p. 0006Commission
- OJ C 276 04.09.1998, p. 0007Commission
- OJ C 296 18.10.2000, p. 0035-0091Commission
- OJ C 317 04.11.1999, p. 0034Commission
- Text adopted · OJ L 018 22.01.2000, p. 0001Commission
- Text adopted · Regulation 2000/0141Commission
- SEC(2006)0832Commission
- Text adopted · T5-0148/1999Parliament
Summary
GeneratedRegulation (EC) No 141/2000 sets a Community procedure for designating orphan medicinal products and provides incentives, including 10-year market exclusivity (reducible to six years). It applies to sponsors seeking designation for conditions affecting not more than five in 10,000 persons. The regulation is in force; the current consolidated version dates from 26 July 2019.
What the workspace adds on this file
Everything above is the public record. In the workspace, subscribers see this file with their own layer on top.
Why it matters to you
What moved
Your contacts on it
A first draft
Sources: EP Legislative Observatory · EU Law Tracker · EUR-Lex. Record as of 30 Sept 2026. Something wrong on this page? Report an error.
Request access
See this file with your own layer on top: why it matters to you, your contacts on it and a first draft. We’ll schedule a 20-minute walkthrough.
Hosted in the EU · Security →
By submitting, you agree to our privacy policy.